Great Valley Advisor Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
8,630
-1,265
-13% -$56.5K 0.01% 810
2026
Q1
$477K Sell
9,895
-3,755
-28% -$175K 0.01% 700
2025
Q4
$661K Sell
13,650
-2,783
-17% -$138K 0.01% 563
2025
Q3
$776K Sell
16,433
-1,012
-6% -$48.8K 0.02% 526
2025
Q2
$843K Sell
17,445
-3,661
-17% -$187K 0.02% 487
2025
Q1
$1.17M Sell
21,106
-2,733
-11% -$148K 0.03% 416
2024
Q4
$1.15M Sell
23,839
-4,168
-15% -$212K 0.03% 412
2024
Q3
$1.61M Sell
28,007
-43,693
-61% -$2.36M 0.04% 340
2024
Q2
$3.48M Buy
71,700
+7,353
+11% +$355K 0.1% 215
2024
Q1
$3.13M Buy
+64,347
New +$3.14M 0.09% 215

Other funds holding SNY

Great Valley Advisor Group's SNY Position: Q2 2026 in Review

Great Valley Advisor Group reduced its Sanofi (SNY) stake by 13% in Q2 2026, selling an estimated $56.5K and leaving 8,630 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #810.

Great Valley Advisor Group first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.48M in Q2 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Great Valley Advisor Group held 8,630 shares of Sanofi worth $368K as of Q2 2026.
  • Great Valley Advisor Group sold 1,265 Sanofi shares in Q2 2026, an estimated $56.5K.
  • Sanofi made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #810 holding.
  • Great Valley Advisor Group first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
  • Great Valley Advisor Group's Sanofi position peaked at $3.48M in Q2 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.